Analytes/procedures in
bold type are regulated for proficiency testing by the Centers for Medicare & Medicaid Services (CMS).
Additional Information
- The BRCA1/2 program is designed for laboratories testing for the three Ashkenazi Jewish founder mutations.
Program Information
- Three 50.0‑μg extracted DNA specimens per disease/gene
Shipping Schedule
-
Shipment A: June 12
-
Shipment B: November 20